1,500
Participants
Start Date
August 1, 2023
Primary Completion Date
October 15, 2027
Study Completion Date
October 15, 2027
Non-Interventional
This is an observational study
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Geisinger Health Systems, Danville
RECRUITING
University of Maryland Medical Center, Baltimore
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Levine Cancer Institute, Charlotte
RECRUITING
Emory University, Atlanta
RECRUITING
Georgia Cancer Center, Augusta
RECRUITING
Mayo Clinic Jacksonville, Jacksonville
RECRUITING
AdventHealth Orlando, Orlando
RECRUITING
Moffit Cancer Center, Orlando
RECRUITING
University of Alabama Birmingham, Birmingham
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
The Ohio State University, Columbus
RECRUITING
Corewell Health, Grand Rapids
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Mayo Clinic Rochester, Rochester
RECRUITING
Loyola University Medical Center, Maywood
RECRUITING
Northwestern University, Chicago
RECRUITING
Rush University Medical Group, Chicago
RECRUITING
The University of Chicago, Chicago
RECRUITING
The University of Kansas Clinical Research Center, Fairway
COMPLETED
Tulane Cancer Center, New Orleans
RECRUITING
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
RECRUITING
University of Colorado, Aurora
RECRUITING
University of Utah, Huntsman Cancer Institute, Salt Lake City
RECRUITING
Mayo Clinic Arizona, Phoenix
RECRUITING
USC Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
City of Hope, Duarte
RECRUITING
Oregon Health Sciences University, Portland
RECRUITING
Fred Hutchinson Cancer Research Center, Seattle
RECRUITING
Massachusetts Cancer Research Center, Boston
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
Lead Sponsor
Incyte Corporation
INDUSTRY